Alexander Drijver

X-Chem, Inc.

Immense opportunities are within reach. X-Chem is the partner you need to unlock exponential possibilities in your small molecule drug discovery. We empower you to screen billions of compounds against your target with our groundbreaking DNA-encoded library (DEL) screening platform. No other partner understands DEL like X-Chem — our experts invented DEL-driven drug discovery and will help you leverage it with unprecedented speed and clarity. Small molecules hold exponential possibilities. Find your next candidate with X-Chem. We have demonstrated our success both internally and with external partnerships by tackling some of the most difficult, intractable targets such as: -protein:protein interactions (PPI) -antibacterial targets -ubiquitin ligases -epigenetic targets -GPCRs We have established collaborations with eight of the leading pharmaceutical companies in the world, including among others: Roche, AstraZeneca, Bayer and Pfizer. We also have partnerships with top tier biotechnology companies, academic centers and non-profit institutions. We have generated novel lead compounds against dozens of high-value therapeutic targets, leading to licensing of multiple lead series by our partners.